[Persistent hyperinsulinemic hypoglycemia of infancy (PHHI)].
Yamada
Y
Y
Department of Metabolism and Clinical Nutrition, Faculty of Medicine, Kyoto University.
D000255:Adenosine Triphosphate / Q000378:metabolism; D003981:Diazoxide / Q000627:therapeutic use; D019204:GTP-Binding Proteins / Q000235:genetics; D016695:Glycosyltransferases; D006801:Humans; D006946:Hyperinsulinism / Q000209:etiology* / Q000628:therapy; D007003:Hypoglycemia / Q000209:etiology* / Q000628:therapy; D017874:Immediate-Early Proteins / Q000235:genetics; D007223:Infant; D007328:Insulin / Q000378:metabolism; D007515:Islets of Langerhans / Q000378:metabolism; D008565:Membrane Proteins; D020559:Monomeric GTP-Binding Proteins; D009154:Mutation; D009543:Nifedipine / Q000627:therapeutic use; D015282:Octreotide / Q000627:therapeutic use; D010180:Pancreatectomy; D015221:Potassium Channels / Q000378:metabolism; D012097:Repressor Proteins / Q000235:genetics; D029701:Saccharomyces cerevisiae Proteins
D017874:Immediate-Early Proteins; D007328:Insulin; D008565:Membrane Proteins; D015221:Potassium Channels; D012097:Repressor Proteins; D029701:Saccharomyces cerevisiae Proteins; D000255:Adenosine Triphosphate; D016695:Glycosyltransferases; C092031:SUR1 protein, S cerevisiae; D019204:GTP-Binding Proteins; C490245:GEM protein, human; D020559:Monomeric GTP-Binding Proteins; D009543:Nifedipine; D003981:Diazoxide; D015282:Octreotide